Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 169.52 billion. The enterprise value is 191.44 billion.

Market Cap	169.52B
Enterprise Value	191.44B

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Mar 14, 2025

Share Statistics

Current Share Class	2.51B
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 10.51 and the forward PE ratio is 8.81.

PE Ratio	10.51
Forward PE	8.81
PS Ratio	2.87
PB Ratio	3.79
P/TBV Ratio	16.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.70, with an EV/FCF ratio of 12.14.

EV / Earnings	11.87
EV / Sales	3.51
EV / EBITDA	7.70
EV / EBIT	9.19
EV / FCF	12.14

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.83
Debt / Equity	0.72
Debt / EBITDA	1.20
Debt / FCF	2.04
Interest Coverage	19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE)	39.29%
Return on Assets (ROA)	13.81%
Return on Invested Capital (ROIC)	19.33%
Return on Capital Employed (ROCE)	27.14%
Revenue Per Employee	799,198
Profits Per Employee	217,972
Employee Count	75,000
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

In the past 12 months, Merck & Co. has paid 2.51 billion in taxes.

Income Tax	2.51B
Effective Tax Rate	13.48%

Stock Price Statistics

The stock price has decreased by -44.30% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-44.30%
50-Day Moving Average	69.34
200-Day Moving Average	86.65
Relative Strength Index (RSI)	40.78
Average Volume (20 Days)	180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.25

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 59.14 billion and earned 16.13 billion in profits. Earnings per share was 6.36.

Revenue	59.14B
Gross Profit	45.58B
Operating Income	22.59B
Pretax Income	18.66B
Net Income	16.13B
EBITDA	26.64B
EBIT	22.59B
Earnings Per Share (EPS)	6.36

Full Income Statement

Balance Sheet

The company has 8.54 billion in cash and 32.24 billion in debt, giving a net cash position of -23.70 billion.

Cash & Cash Equivalents	8.54B
Total Debt	32.24B
Net Cash	-23.70B
Net Cash Per Share	n/a
Equity (Book Value)	44.78B
Book Value Per Share	17.77
Working Capital	9.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.32 billion and capital expenditures -3.55 billion, giving a free cash flow of 15.76 billion.

Operating Cash Flow	19.32B
Capital Expenditures	-3.55B
Free Cash Flow	15.76B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin	77.07%
Operating Margin	38.19%
Pretax Margin	31.55%
Profit Margin	27.27%
EBITDA Margin	45.05%
EBIT Margin	38.19%
FCF Margin	26.66%

Dividends & Yields

This stock pays an annual dividend of 2.93, which amounts to a dividend yield of 4.22%.

Dividend Per Share	2.93
Dividend Yield	4.22%
Dividend Growth (YoY)	5.72%
Years of Dividend Growth	4
Payout Ratio	46.05%
Buyback Yield	0.30%
Shareholder Yield	4.52%
Earnings Yield	9.51%
FCF Yield	9.30%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.

Altman Z-Score	4.7
Piotroski F-Score	7